Here are relevant reports on : clinical-trial-imaging-services-market
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
The global Photoacoustic imaging market, valued at US$75M in 2023, is forecasted to grow at a 5.5% CAGR, reaching US$80M by 2024 and US$105M by 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029
The global clinical trial imaging market, valued at US$1.32 billion in 2023, stood at US$1.42 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.07 billion by the end of the period. The increase in R&D spending, growth in the pharmaceutical and biotechnology industry and the increasing number of CROs are driving the clinical trial imaging market.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecast to 2028
The global breast imaging market, valued at US$4.1 billion in 2022, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.5% from 2023 to 2028, culminating in a forecasted valuation of US$6.6 billion by the end of the period.The increasing number of research grants, rising focus on contrast-based diagnostic solutions, and rising awareness in developing economies are expected to drive the market during the forecast period.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) - Forecast to 2024
The European mammography workstations market is estimated to grow at a CAGR of 5.5% to reach USD 14 million by 2024 from USD 10 million in 2018. Factors such as the rising burden of breast cancer, increasing market availability of multimodality diagnostic platforms, and the increasing patient awareness about the clinical benefits associated with the early diagnosis of breast conditions are driving the growth of the European mammography workstations market.General Electric (US), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Siemens (Germany), and FUJIFILM Corporation (Japan) are the major players in the European mammography workstations market. Other prominent players in this market include Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Hyperspectral Imaging Systems Market by Offering (Cameras, Services), Technology (Pushbroom, Snapshot, Tunable Filter, Imaging FTIR, Whiskbroom), Wavelength (Visible & NIR, SWIR, MWIR, LWIR), and Region - Forecast to 2030
The Asia Pacific hyperspectral imaging systems market is expected to be valued at USD 0.23 billion in 2025 and USD 0.48 billion by 2030, exhibiting a CAGR of 16.1% during the forecast period. The Key players Corning Incorporated (US), HORIBA (Japan), Bayspec, INC. (US), SPECIM, SPECTRAL IMAGING LTD. (Finland), and Malvern Panalytical Ltd (UK).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
North America Hyperspectral Imaging Systems Market by Offering (Cameras, Services), Technology (Pushbroom, Snapshot, Tunable Filter, Imaging FTIR, Whiskbroom), Wavelength (Visible & NIR, SWIR, MWIR, LWIR), and Country - Forecast to 2030
North America Hyperspectral Imaging Systems Market
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Europe Hyperspectral Imaging Systems Market by Offering (Cameras, Services), Technology (Pushbroom, Snapshot, Tunable Filter, Imaging FTIR, Whiskbroom), Wavelength (Visible & NIR, SWIR, MWIR, LWIR), and Country - Forecast to 2030
The Europe hyperspectral imaging systems market is projected to be valued at USD 0.28 billion in 2025 and USD 0.56 billion by 2030, exhibiting a CAGR of 15% from 2025 to 2030. The Key Players Corning Incorporated (US), HORIBA (Japan), Bayspec, INC. (US), SPECIM, SPECTRAL IMAGING LTD. (Finland), and Malvern Panalytical Ltd (UK).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Teleradiology Market by Product & Service (Services, Hardware, Software (PACS, RIS)), Imaging Technique (MRI, CT, X-ray, Ultrasound, Mammography, Nuclear Imaging), End User (Hospitals, Diagnostic Centers & Laboratories) & Region - Global Forecast to 2026
The global teleradiology market growth is primed to transition from $7.3 billion in 2021 to $14.8 billion by 2026, showcasing a strong CAGR of 15.3%. Key growth drivers include the rising elderly population, increased imaging procedures, a shortage of radiologists, and technological advancements like cloud-based solutions and artificial intelligence (AI).
- Published: January 2022
- Price: $ 4950
- TOC Available:
-
Veterinary Imaging Market by Product (CT, MRI, Imaging Systems, Imaging Reagents, Imaging Software, Accessories), Animal Type (Small, Large), Application (Oncology, Dentistry), Modality (Portable, Stationary), End User, Region - Global Forecast to 2031
The global veterinary imaging market, valued at US$2.13 billion in 2025, stood at US$2.29 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$3.33 billion by the end of the period. This growth is driven by several factors, including an increase in pet ownership, rising spending on animal healthcare, a growing demand for early and accurate diagnosis, and advancements in imaging technologies such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI).
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
